G171D (p.Gly171Asp) variant of GLA (Alpha-galactosidase A)
G171D (p.Gly171Asp) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of Cardiovascular phenotype; Fabry disease. The record also includes published literature and structural context.
G171D (p.Gly171Asp) variant details
- p.Gly171Asp
- rs2520895216
- ClinGen CA413928836
- ClinVar RCV002344217
- ClinVar RCV003340486
- Pathogenic/Likely pathogenic
- Cardiovascular phenotype; Fabry disease
- Missense
- ClinVar: Pathogenic/Likely pathogenic (Cardiovascular phenotype; Fabry disease)
- EBI: Pathogenic (in FABRYD)
- UniProt: Pathogenic (in FABRYD)
- Structural context available
- Cited in: Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography. (PMID 15712228)
- Cited in: Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. (PMID 12735292)